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Initiating events in prostate cancer: The role of somatic activation of [-catenin. Introduction. Histopathological studies of prostate cancers have led to the identification of prostate intra epithelial neoplasia (PIN), a specific type of lesion that represents the primary precursor of human prostate cancer (2) . PIN is recognized as a continuum between lowgrade and high-grade forms, with high-grade PIN most likely representing the immediate precursor of early invasive carcinoma. Characteristic architectural and cytological features are shared between PIN lesions and early invasive carcinomas including multifocal nature of the lesions, and common chromosomal abnormalities (reviewed in (3)). We have reported characteristic appearance of PINs upon stabilization of [3-catenin in the prostate (4) . This observation is in line with the deregulation of PI3kinase activity in prostate cancer (5) , and recent observations that link Pl3kinase activity with the accumulation of 13-catenin and stimulation of the androgen receptor signaling (6, 7) . In our earlier study, stabilization of P-catenin was achieved through Cre/loxP mediated excision of the third exon of P3-catenin. This model was based on the MMTV-LTR driven expression of Cre in a wide range of secretory epithelia, and skin. Preneoplastic lesions were observed only in the prostate, suggesting a specific role for P-catenin in the initiation of prostate cancer. The research underway aims to clarify the role of P3-catenin in prostate cancer, its relevance to human prostate cancer, and the cross talk of this signaling pathway with other events associated with human prostate cancer.
Body. Task 1&2. To establish the role of P-catenin in the initiation of prostatic intraepithelial neoplasia (PIN) like lesions, & determine targets of oncogenic action of P-catenin.
We have achieved prostate specific expression of Cre under the minimal probasin (PB) promoter (8) , or the prostate specific antigen (PSA) promoter. The PSA-Cre mice were the genetic cause of human colon cancer. In contrast to frequent APC defects, mutations affecting the 13-catenin gene are rare in colon cancer. These facts suggest that although the stabilization of P3-catenin efficiently promotes pre-neoplasia, by itself it may not be sufficient to cause malignancy. In a collaborative study with Dr. Fotini Gounari we have begun to gain insight into this issue, by comparing the impact of mutations that lead to the loss of APC with those that directly stabilize [3-catenin. By introducing the corresponding Cre dependent conditional mutations in lymphocytes, we have shown that loss of APC leads to blockage of mitosis and that escape from this block requires aberrant chromosome segregation. As a result dividing cells that are deficient for APC are inherently genetically unstable. In contrast, direct stabilization of 13-catenin leads to aberrant proliferation and differentiation of immature lymphocytes. These observations indicate that genetic instability associated with the loss of APC may be a critical factor in promoting the malignant transition of the lesions, and that the stabilization of 13-catenin in the presence of intact APC function may therefore not be sufficient for tumor progression (manuscript submitted). We are currently comparing prostate specific loss of APC with stabilization of P3-catenin to gain further insights into the role of genomic instability in tumor progression in the prostate. So far, we have confirmed occurrence of PINs in mice that have lost APC function in a prostate specific manner. Further work is underway to compare proliferation and genetic stability of prostate epithelial cells in the two types of mice, and to relate these to the ability of the lesions to progress to malignancy. The lesions caused by PSA-Cre appear to be massively infiltrated with inflammatory cells. We had earlier reported the use of protease activatable fluorescent probes for imaging of adenomatous polyps (1) . The presence of proinflammatory leukocytes in the prostatic lesions encouraged us to apply similar imaging techniques to the prostate. To this aim 3-7 months old PSA-Cre x Catnb+/ox(ex 3 ) mice were injected with Cathepsin-B sensitive probe with emission maximum of 694, 24 hours in advance. The next day the mice were anesthetized, injected with a fluorescent polymer that emits at 750 nm and reveals blood vessels, and prostates were imaged by intra vital fluorescent confocal microscopy using a x4 lens. The imaging analysis revealed in situ Cathepsin activity in diseased prostates, with abundant neo-angiogenesis supplying the lesions (Fig. 2) . To reveal the cellular source of the proteolytic activity in the lesions we prepared single cell suspensions of the entire diseased prostates by limited collagenase digestion, and separated the epithelial from the leukocyte cell populations using percoll gradient centrifugation. Cell surface staining and FACS analysis revealed CD1 lb+Grl+ cells as the cellular source of the Cathepsin signal. These observations suggest that stabilization of 13-catenin and initiation of prostate cancer coincide with local inflammatory reactions that contribute to the elevated proteolytic activity of the tumor micoenvironment.
Task 3.
To test the hypothesis that P-catenin induced lesions can progress to carcinomas. The cooperation of PTEN/Akt-1 pathway with P3-Catenin. Lesions produced by the stabilization of P3-catenin in the prostate are preneoplastic and non-invasive, suggesting that additional genetic mutations may be required for tumor progression. PTEN (Phosphatase and tensin deleted on chromosome 10) mutations have been frequently associated with progression in prostate cancer, and are present in 30% of primary (11) (12) and 63% of metastati prostate cancers (13) . In mice, prostate specific loss of PTEN predisposes the animals to metastatic prostate cancer (14) (15) (16) . Interestingly genetic deficiency in PTEN in humans is associated with at least two hereditary Hamartoma disorders, Cowden's syndrome (CS) and Bannayan-RileyRuvalcaba syndrome (BRRS). These are typically diseases of inflammatory nature with predisposition to cancer. It was therefore postulated that deficiency in PTEN may promote malignant progression of the 13-catenin induced PINs, and that the progressive tumors would have an inflammatory nature. To test this, we introduced a heterozygous PTEN deficient allele in PBCre x Catnb+flOx(ex 3 ) mice. At 3 months of age mice containing all three mutations harbored invasive prostate cancer with a strong inflammatory component (Fig. 3) . Imaging of the mice with Cathepsin activated fluorescent probes revealed strong proteolytic activity within the prostate. Imaging of the vasculature feeding the lesions revealed abnormally expanded and thin walled vessels, characteristic of tumor vasculature. Rapid leakage of the imaging probe indicated leakiness of the vessels, which is also characteristic of blood vessels in advanced tumors (Fig. 4) . !V These observations are consistent with deregulation of 13-catenin in primary prostate cancer, and with the loss of PTEN contributing to tumor progression. Furthermore they implicate inflammation in the process of tumor progression. Recent works from several laboratories have suggested that inflammation may play a determining role in facilitating the growth and progression of tumors. In transgenic models of skin cancer inhibition of proteolytic activity associated with tumor infiltrating pro-inflammatory leukocytes, or depletion of CD4+ T cells leads to significant delay and suppression of tumorigenesis (17) (18) (19) . These reports implicate host inflammatory responses in the acceleration of tumor progression. In mouse models of colon cancer CD4+CD25+ immune suppressor cells play a significant role in slowing down the growth of adenomas (20, 21) . Our The images here are from the same mouse and correspond to the histology shown in Figure 4b . The mouse was injected with probes for imaging cathepsin activity and angiogenesis and mice were imaged, as described in Figure 3 . Note extensive areas with Cathepsin activity and distorted image of supplying blood vessels, due to leakage of the probe from the vessels. The image on the left is an overlapped image of the two images on the right. Cathepsin activity is pseudo-colored as green, and blood vessels as red.
unpublished results suggest that this may be due to the suppression of innate inflammatory responses to the intestinal lesions. The major components of these inflammatory reactions are macrophages, neutrophils and mast cells, the same cells seen to infiltrate prostatic lesions in our studies. Altogether, the reports and our unpublished observations suggest that stabilization of [-catenin and the cooperative effect of PTEN lead to the progressive growth of invasive prostate cancer, and that the extent of inflammation in the lesions may be predictive of the advanced/malignant nature of the lesion. We are currently testing these hypotheses by crossing our mice to Cathepsin-B deficient mice, as well as by manipulating the host responses to the tumors.
Key research accomplishments (2004-2005
).
-It was demonstrated that stabilization of [-catenin in the prostate secretory epithelia, is responsible for the initiation of PIN.
-It was demonstrated that these lesions in the mouse do not progress to malignancy at least with the first 1/3 life span of the mouse.
-Preliminary observations suggest that the inability of the above lesions to progress may be related to the genetic integrity of aberrant cells; in contrast loss of APC leads to genetic instability.
-Stabilization of 13-catenin was linked to local inflammatory reactions.
-Malignant progression of the 13-catenin induced lesions was achieved by introducing a heterozygous defect in PTEN.
-Tumor progression was linked with increased inflammation and local proteolytic activity. Reportable outcomes. The first year focused our attention on improving and characterizing the animal models, as well as relating our observations to human prostate cancer. In the second year, we established the benign nature of transformation by [3-catenin and addressed the possibility that this may be related to the genetic integrity of the lesions. We provided evidence for the cooperation of P-catenin signaling with PTEN deficiency in promoting malignant progression of prostate cancer. Furthermore, we linked tumor progression with local inflammatory reactions.
Conclusions.
Using different transgenic mice we were able to demonstrate that the target of transformation by P3-catenin in the prostate is the secretory epithelia. We have provided evidence for the benign nature of transformation by 13-catenin and the conversion of this benign phenotype to invasive cancer upon heterozygous loss of PTEN. Local inflammatory reactions are inherently associated with and contribute to the local tumor microenvironment, suggesting a crosstalk between tumor and host immune response that may be contributing to the success of the tumor. Future work will focus on the contribution of the PTEN mutation to tumor progression, the contribution of local inflammatory responses, and studies of downstream targets of 13-catenin in the prostate physiology and cancer. 
